TGR-1202 in CLL and Non-Hodgkin lymphoma

Howard Burris, MD from Sarah Cannon, Nashville, TN discusses TGR-1202 for chronic lymphocytic leukemia (CLL) and Non-Hodgkin lymphoma (NHL). TGR-1202 is a PI3K delta inhibitor and Dr Burris discusses ... Author: VJHemOnc Added: 07/05/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts